SCHEMBL8364014

SCHEMBL8364014

C=C1c2ccc([N+](=O)[O-])cc2C(=O)N1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.63
NR1H3 Q13133 1/20 0.63
CASP1 P29466 1/20 0.60
CASP3 P42574 1/20 0.60
CASP4 P49662 1/20 0.60
CASP7 P55210 1/20 0.60
CASP9 P55211 1/20 0.60
CASP6 P55212 1/20 0.60
PTPRC P08575 3/20 0.51
S100A4 P26447 2/20 0.51
CYP3A4 P08684 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 2/20 0.47
ACHE P22303 2/20 0.47
ALOX5 P09917 1/20 0.47
BCHE P06276 1/20 0.46
CES1 P23141 1/20 0.46
LMNA P02545 1/20 0.46
CA12 O43570 3/20 0.46
CA9 Q16790 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL516995 0.86 CASP1 (0.63) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL29945629 0.86 CASP1 (0.63) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL1704508 0.76 PTPRC (0.58) NR1H2NR1H3CASP1CASP3CASP4
Phthalimide SCHEMBL27559674 0.76 CYP3A4 (0.67) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL31268227 0.75 CASP1 (0.54) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL26621563 0.75 CASP3 (0.77) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL30232255 0.75 CASP3 (1.00) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL3594484 0.75 CASP3 (1.00) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL31419431 0.73 CASP3 (0.72) NR1H2NR1H3CASP1CASP3CASP4
SCHEMBL8090142 0.73 ACHE (0.62) ALDH1A1ACHEALOX5CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003020721-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2003-03-13 WO disclosed